Mexican-Americans face different – and perhaps greater – risks for developing liver cancer than Mexican residents. Liver cancer is a relatively rare cancer type, but its incidence and mortality have been on the rise...
A study suggests working within a religious framework may help eas cultural barriers to cancer screening with mammograms.
A new study showed that one in five young, non-Hispanic white women who tan indoors are dependent on the activity.
A study finds that participation in clinical trials by African-Americans and Hispanics has declined over the last two decades.
Treatment may improve survival for older colorectal cancer patients with dementia, but chemo can be challenging and some may choose to forego care.
The FDA approved a molecularly targeted therapy for treating patients with a certain form of breast cancer.
The FDA expanded an immunotherapeutic to used for treating patients with hepatocellular carcinoma – the most common form of primary liver cancer.
The FDA expanded the use of an immunotherapeutic to include the treatment of certain patients with stomach cancer (gastric cancer).
The FDA approved a molecularly targeted therapy for treating certain adults with follicular lymphoma, a form of non-Hodgkin lymphoma.
The FDA has approved a CD22-targeted antibody-drug conjugate for treating certain adults with ALL. The U.S. Food and Drug Administration (FDA) recentlyapproved a new molecularly targeted therapeutic called inotuzumab ozogamicin (Besponsa) for treating certain...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More